Developer and manufacturer of minimally invasive treatments for vascular diseases
Endologix (Nasdaq: ELGX) developed innovative medical devices for the treatment of aortic abdominal aortic aneurysms. In 2010, Essex Woodlands made an investment in Endologix, concurrently selling its other portfolio company, Nellix Endovascular, to Endologix.